Overexpression of LINC00472 in Breast Cancer
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization :
Other organizations : University of Hawaiʻi at Mānoa, University of Hawaii System, Tongren Hospital, Shanghai Jiao Tong University
Variable analysis
- Transfection of LINC00472 plasmid or empty plasmid (pCDH vector only) into MB231 and Hs578T cells
- Transfection of pCMV-ESR1 plasmid with or without full-length human ESR1 into 293T cells and breast cancer cell lines
- Stable expression of LINC00472
- Overexpression of ESR1
- Lipofectamine 3000 reagent for transfection
- Puromycin selection and maintenance of stably transfected cells
- Limiting dilution cloning to generate single cell clones
- Positive control: pCMV-ESR1 plasmid with full-length human ESR1
- Negative control: pCMV-vector (empty plasmid)
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!